CLDX
Celldex Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CLDX fundamentals
Celldex Therapeutics (CLDX) released its earnings on Nov 10, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -1.01 (YoY -57.81%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-1.01
-57.81%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Celldex Therapeutics (CLDX) key financial stats and ratios, covering profitability, financial health, and leverage.
Celldex Therapeutics (CLDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Celldex Therapeutics (CLDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Celldex Therapeutics (CLDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Celldex Therapeutics (CLDX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Celldex Therapeutics (CLDX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Celldex Therapeutics do and what are its main business segments?What is Celldex Therapeutics's gross profit margin?What factors drove the changes in Celldex Therapeutics's revenue and profit?What is the market's earnings forecast for Celldex Therapeutics next quarter?What is Celldex Therapeutics's latest dividend and current dividend yield?What guidance did Celldex Therapeutics's management provide for the next earnings period?What were the key takeaways from Celldex Therapeutics’s earnings call?Did Celldex Therapeutics beat or miss consensus estimates last quarter?
